MedTrace Logo

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

NCT00217165 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-03-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.

Conditions

Interventions

DRUG

taurine

taurine 2mg BID po

Sponsors & Collaborators

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Beth L Murphy, MD, PhD · Mclean Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2010-01-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00217165 on ClinicalTrials.gov